R01CA274952
Project Grant
Overview
Grant Description
Epigenetic study of oral HPV infection-associated oral cancer in people living with HIV in Nigeria.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Chicago,
Illinois
606114407
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 233% from $743,534 to $2,473,088.
Northwestern University was awarded
Project Grant R01CA274952
worth $2,473,088
from National Cancer Institute in September 2022 with work to be completed primarily in Chicago Illinois United States.
The grant
has a duration of 4 years and
was awarded through assistance program 93.395 Cancer Treatment Research.
The Project Grant was awarded through grant opportunity Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 8/20/24
Period of Performance
9/16/22
Start Date
8/31/26
End Date
Funding Split
$2.5M
Federal Obligation
$0.0
Non-Federal Obligation
$2.5M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for R01CA274952
Transaction History
Modifications to R01CA274952
Additional Detail
Award ID FAIN
R01CA274952
SAI Number
R01CA274952-3335933048
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
KG76WYENL5K1
Awardee CAGE
01725
Performance District
IL-05
Senators
Richard Durbin
Tammy Duckworth
Tammy Duckworth
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,693,991 | 100% |
Modified: 8/20/24